Skip to main content

Table 3 Comparison of survival, recurrence, and metastasis rates between the two groups after 3 years of treatment [n(%)]

From: Cisplatin combined with capecitabine-induced chemotherapy for local nasopharyngeal carcinoma can improve the quality of life and reduce toxic and side effects

Category Group A (n=66) Group B (n=70) χ2 value p value
Survival rate 47 (77.27) 60 (85.71) 4.259 0.039
Recurrence rate 13 (19.70) 5 (7.14) 4.662 0.030
Metastasis rate 15 (22.73) 7 (10.00) 4.058 0.044